E

Esperion Therapeutics
D

ESPR

1.08000
USD
0.10
(10.47%)
Market Closed
Volume
116,233
EPS
-0
Div Yield
-
P/E
-4
Market Cap
214,001,375
Related Instruments
ABBV
ABBV
5.160
(2.67%)
198.440 USD
A
ALKS
1.225
(4.01%)
31.785 USD
AMGN
AMGN
-2.15
(-0.76%)
281.20 USD
BMY
BMY
1.000
(2.02%)
50.560 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
JNJ
JNJ
1.720
(1.11%)
156.120 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
PFE
PFE
0.065
(0.27%)
24.185 USD
REGN
REGN
15.98
(2.71%)
606.12 USD
More
News

Title: Esperion Therapeutics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.